Heat Shock Proteins in Lymphoma Immunotherapy

Heat Shock Proteins in Lymphoma Immunotherapy

Immunotherapy harnessing the host immune system for tumor destruction revolutionized oncology research and advanced treatment strategies for lymphoma patients. Lymphoma is a heterogeneous group of cancer, where the central roles in pathogenesis play immune evasion and dysregulation of multiple signa...

Full description

Bibliographic Details
Main Authors:	Zarema Albakova, Yana Mangasarova, Alexander Sapozhnikov
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-03-01
Series:	Frontiers in Immunology
Subjects:	heat shock proteins lymphoma CAR T CAR NK checkpoint inhibitors
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.660085/full

Similar Items

Heat Shock Proteins in Urine as Cancer Biomarkers
by: Zarema Albakova, et al.
Published: (2021-10-01)

Extracellular heat shock proteins and cancer: New perspectives
by: Zarema Albakova, et al.
Published: (2021-02-01)

Current Immunotherapy Approaches in Non-Hodgkin Lymphomas
by: Robert Pytlik, et al.
Published: (2020-11-01)

The Role of Heat Shock Protein 70 kDa in Asthma
by: Shevchenko M, et al.
Published: (2021-01-01)

CAR-macrophage: A new immunotherapy candidate against solid tumors
by: Yizhao Chen, et al.
Published: (2021-07-01)

Superior Expansion and Cytotoxicity of Human Primary NK and CAR-NK Cells from Various Sources via Enriched Metabolic Pathways
by: Yan Yang, et al.
Published: (2020-09-01)

New developments in immunotherapy for lymphoma
by: Benjamin Heyman, et al.
Published: (2018-09-01)

Editorial: Molecular Strategies Aimed to Boost NK Cell-Based Immunotherapy of Cancer
by: Loredana Cifaldi, et al.
Published: (2020-06-01)

Early Evaluation of Immunotherapy Response in Lymphoma Patients by 18F-FDG PET/CT: A Literature Overview
by: Cristina Ferrari, et al.
Published: (2021-03-01)

Newest Approaches in Immunotherapy for Non-Hodgkin’s Lymphoma
by: Emily C. Ayers, et al.
Published: (2018-12-01)

The heat shock protein 90 inhibitor BIIB021 suppresses the growth of T and natural killer cell lymphomas
by: Michio eSuzuki, et al.
Published: (2015-04-01)

The Evolution of Cancer Immunotherapy
by: Meshaal Khan, et al.
Published: (2021-06-01)

Heat Shock proteins expression in different types of classical Hodgkin`s Lymphoma
by: Tumanskiy V.O., et al.
Published: (2013-01-01)

New Orders to an Old Soldier: Optimizing NK Cells for Adoptive Immunotherapy in Hematology
by: Mehmet Gunduz, et al.
Published: (2021-09-01)

Mechanisms of Resistance to NK Cell Immunotherapy
by: Christian Sordo-Bahamonde, et al.
Published: (2020-04-01)

Targeting Natural Killer Cells for Tumor Immunotherapy
by: Cai Zhang, et al.
Published: (2020-02-01)

Immunotherapy in Glioblastoma: A Clinical Perspective
by: Nicolas Desbaillets, et al.
Published: (2021-07-01)

Challenges and Opportunities for Effective Cancer Immunotherapies
by: Clare Y. Slaney, et al.
Published: (2020-10-01)

Molecular Strategies Aimed to Boost NK Cell-based Immunotherapy of Cancer
Published: (2020)

Editorial: Targeting the PD-1/PD-L1 Cancer Immune Evasion Axis: Challenges and Emerging Strategies
by: Yiting Wang, et al.
Published: (2020-09-01)

New Frontiers about the Role of Human Microbiota in Immunotherapy: The Immune Checkpoint Inhibitors and CAR T-Cell Therapy Era
by: Vanessa Innao, et al.
Published: (2020-11-01)

NK Cells in the Treatment of Hematological Malignancies
by: Ana P Gonzalez-Rodriguez, et al.
Published: (2019-09-01)

Immunotherapy with NK cells: recent developments in gene modification open up new avenues
by: Lisa Marie Reindl, et al.
Published: (2020-01-01)

Adoptive Immunotherapy beyond CAR T-Cells
by: Aleksei Titov, et al.
Published: (2021-02-01)

The Intriguing History of Cancer Immunotherapy
by: Paula Dobosz, et al.
Published: (2019-12-01)

Cell‐based and antibody‐mediated immunotherapies directed against leukemic stem cells in acute myeloid leukemia: Perspectives and open issues
by: Peter Valent, et al.
Published: (2020-11-01)

Cancer immunotherapy: Pros, cons and beyond
by: Shuzhen Tan, et al.
Published: (2020-04-01)

The Heat-Stable Enterotoxin Receptor, Guanylyl Cyclase C, as a Pharmacological Target in Colorectal Cancer Immunotherapy: A Bench-to-Bedside Current Report
by: Trevor R. Baybutt, et al.
Published: (2017-09-01)

Adenovirus and Immunotherapy: Advancing Cancer Treatment by Combination
by: Mizuho Sato-Dahlman, et al.
Published: (2020-05-01)

Combination strategies to maximize the benefits of cancer immunotherapy
by: Shaoming Zhu, et al.
Published: (2021-09-01)

CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
by: Chittepu, V.C.S.R, et al.
Published: (2022)

Advances in Immunotherapy for Adult Glioblastoma
by: Chirayu R. Chokshi, et al.
Published: (2021-07-01)

Novel therapeutic strategies in human malignancy: combining immunotherapy and oncolytic virotherapy
by: Sampath P, et al.
Published: (2015-06-01)

Current Immunotherapeutic Approaches in T Cell Non-Hodgkin Lymphomas
by: Teresa Poggio, et al.
Published: (2018-09-01)

Mouse Tumor Models for Advanced Cancer Immunotherapy
by: Daria S. Chulpanova, et al.
Published: (2020-06-01)

CAR-Based Strategies beyond T Lymphocytes: Integrative Opportunities for Cancer Adoptive Immunotherapy
by: Ramona Rotolo, et al.
Published: (2019-06-01)

Targeting T cell malignancies using CAR-based immunotherapy: challenges and potential solutions
by: Lauren C. Fleischer, et al.
Published: (2019-12-01)

Evaluating tisagenlecleucel and its potential in the treatment of relapsed or refractory diffuse large B cell lymphoma: evidence to date
by: Zavras PD, et al.
Published: (2019-06-01)

CAR-T “the living drugs”, immune checkpoint inhibitors, and precision medicine: a new era of cancer therapy
by: Delong Liu
Published: (2019-11-01)

Immunotherapy in Multiple Myeloma
by: Cinnie Yentia Soekojo, et al.
Published: (2020-03-01)

Cannot write session to /tmp/vufind_sessions/sess_3e87bo4tebif1vc451guptlsni